22 matches for your search in the start-up spotlight
rss
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base ...
Technology to support sustainable agriculture one microbe at a time. Chemical fertilizers and pesticides have long been the go to solution for farmers looking to enhance their yields. We believe that nature has a viable alternative to replace chemicals, it just needs some help. We have developed ...
NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 ...
METiS Therapeutics is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas. The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism-driven quantum mechanics and molecular ...
Cellino is on a mission to make personalized, autologous cell therapies accessible for patients. Stem cell-derived regenerative medicines are poised to cure some of the toughest diseases within this decade, including Parkinson’s, diabetes, and heart disease. Patient-specific cells provide the ...
EQRx is a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices. Launched in January 2020, EQRx is purpose-built, at scale, with a growing catalog of medicines in development in high-cost drug categories and emerging ...
Biobot Analytics develops cutting-edge technology to transform sewers into public health observatories. Wastewater contains valuable information about the health of communities. We collect it. We analyze it. We tell you how to leverage it to make your city better. Our first product is to measure ...
At Quench Bio we are discovering inhibitors of novel targets in innate immunity, the gasdermins. A central player in multiple pathways leading to inflammatory cell death, Gasdermin D acts as the executioner of pyroptosis and NETosis. By targeting this core node in innate immunity, we will inhibit ...
eGenesis is a gene editing and genome engineering company committed to the development of safe and effective human transplantable organs, tissues and cells to address the global organ crisis.
The Kebotix self-driving lab combines data and AI with robotics to discover and create advanced chemicals and materials at a faster rate and at the push of a button. Kebotix offers inventive solutions that create new, disruptive chemistries and materials at a rapid pace while reducing costs. Our ...
